BCL2L11 and breast carcinoma: Similarily, the Receptor for activated C kinase 1 (RACK1) has been shown to confer paclitaxel resistance to breast cancer cells by binding to both the dynein light chain 1 and BimEL upon exposure to paclitaxel [551].